SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-007878
Filing Date
2019-05-20
Accepted
2019-05-20 16:06:35
Documents
52
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 884124
2 ex31-1.htm EX-31.1 18984
3 ex31-2.htm EX-31.2 18814
4 ex32-1.htm EX-32.1 8192
5 ex32-2.htm EX-32.2 8037
  Complete submission text file 0001493152-19-007878.txt   4301508

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE rspi-20190331.xml EX-101.INS 745512
7 XBRL SCHEMA FILE rspi-20190331.xsd EX-101.SCH 64129
8 XBRL CALCULATION FILE rspi-20190331_cal.xml EX-101.CAL 38952
9 XBRL DEFINITION FILE rspi-20190331_def.xml EX-101.DEF 195303
10 XBRL LABEL FILE rspi-20190331_lab.xml EX-101.LAB 375141
11 XBRL PRESENTATION FILE rspi-20190331_pre.xml EX-101.PRE 253820
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
RespireRx Pharmaceuticals Inc. (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16467 | Film No.: 19838782
SIC: 2834 Pharmaceutical Preparations